Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA campus consolidation revised budget of $810 mil. seeks reductions in design, engineering costs.

Executive Summary

FDA CAMPUS: $80 MIL. GSA SCALE-BACK FOR CONSOLIDATION was greeted favorably by House Transportation & Infrastructure/ Public Buildings & Economic Development Subcommittee Chairman Rep. Gilchrest (R-Md.) at a March 6 hearing on the proposed budget for the agency's consolidated campus. "The original cost of the project was considerably larger than the current scope of this project," Gilchrest observed. The revised $810 mil. cost estimate is $80 mil. less than the agency's original projection of $890 mil. and half-a-billion dollars below initial 1990 estimates of $1.4 bil.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel